SINOVAC VACCINE HALAL CONTROLLERS: ACCORDING TO THE LAY COMMUNITY
KONTROVERSI KEHALALAN VAKSIN SINOVAC: MENURUT MASYARAKAT AWAM
Abstract
Salah satu upaya untuk menekan angka kasus COVID-19 yang kian meningkat adalah dengan penyediaan vaksin COVID-19 dari pemerintah. Meski masih dalam tahap uji klinis, keberadaan vaksin ini diharapkan dapat melindungi masyarakat Indonesia dari pandemi. Dari sekian banyak pembahasan tentang Covid-19 dan vaksinnya, satu hal yang tak boleh dilupakan adalah kehalalan vaksin tersebut. Beberapa buku, artikel, dan media massa dijadikan rujukan untuk memahami studi ini. Dan disimpulkan bahwa vaksin Covid-19 yang telah sampai di Indonesia dan akan disuntikkan ke masyarakatnya terbukti halal dan boleh digunakan. Tentu saja, selain vaksin, masyarakat juga diharapkan dapat terus menjaga kesehatan dirnya masing-masing dengan tetap menjalankan protokol kesehatan Covid-19.
This work is licensed under a Lisensi Creative Commons Atribusi 4.0 Internasional.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
